Vossius & Partner

This mixed IP firm has recognized the sign of the times and is currently pushing the expansion of its litigation practice more strongly than its competitors. After all, prosecution work in general is coming under growing pressure. Vossius is thus looking to take on more litigation. If the UPC should launch, the firm wants to be at the forefront. To demonstrate this, it expanded its Düsseldorf office in impressive fashion with three litigators from Arnold Ruess, who brought client Wiko, a mobile communications manufacturer frequently taken before the German courts at present. This was significant because the litigation team has not been as strong as it could be in mobile communications suits lately. The Munich litigators were able to represent another Chinese mobile communications provider in an NPE suit. The patent attorneys with litigation experience have also been working for ZTE for some time. Now Munich litigators Dr. Thure Schubert and Dr. Georg Rauh are using an NPE suit to position themselves more strongly in the market on the side of ZTE. Extensive litigation work for medical product manufacturers like ResMed and Smith & Nephew also contributed to this. Highly renowned patent attorneys Dr. Hans-Rainer Jaenichen and Dr. Alexa von Uexküll impressively demonstrated how Vossius is playing in the top league in pharmaceuticals and biotech proceedings. Jaenichen’s central role for CRISPR Therapeutics in the high-profile opposition suit against a basic patent for the new technology rounded off Vossius’ successful year.